Filter
2093
Filtered Results: 2093
Text search:
pharmaceutical
needs
Featured
Recommendations
184
New Publications
555
Language
Document type
No document type
1080
Studies & Reports
412
Guidelines
298
Manuals
99
Strategic & Response Plan
91
Fact sheets
47
Training Material
28
Situation Updates
17
Resource Platforms
8
Infographics
7
Brochures
4
Online Courses
2
Countries / Regions
India
86
Kenya
82
Ethiopia
80
Global
79
South Africa
54
Western and Central Europe
47
Nigeria
45
Uganda
41
Liberia
39
Sierra Leone
37
Namibia
30
Ghana
29
Rwanda
29
Tanzania
29
Nepal
28
Africa
28
Malawi
27
Zambia
27
Bangladesh
25
Ukraine
24
Philippines
20
Syria
19
Zimbabwe
19
Eastern Europe
19
Cambodia
18
Latin America and the Carribbean
18
Lesotho
17
South–East Asia Region
15
Indonesia
14
West and Central Africa
13
Botswana
12
Congo, Democratic Republic of
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
East and Southern Africa
10
Germany
9
Eastern Europe and Central Asia
9
South Sudan
9
Cameroon
8
Asia
8
Venezuela
8
Middle East and North Africa
7
Thailand
6
Senegal
6
Burkina Faso
6
Guinea
6
Haiti
6
Albania
5
Mozambique
5
Western Pacific Region
5
Russia
5
Pakistan
5
Laos
4
Vietnam
4
Papua New Guinea
4
North Macedonia
3
Benin
3
China
3
Fiji
3
Afghanistan
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Lebanon
3
Brazil
3
Egypt
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Chile
2
Kyrgyzstan
2
Peru
2
Lithuania
2
Jamaica
2
Southern Africa
2
Moldova
2
Yemen
2
Georgia
2
Central African Republic
2
Iraq
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Kazakhstan
1
Iran
1
Canada
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Sri Lanka
1
Romania
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
844
Clinical Guidelines
139
Public Health
112
Key Resources
74
Women & Child Health
51
Pharmacy & Technologies
32
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
AMR
204
Pharmacy
188
COVID-19
174
Mental Health
123
HIV
112
TB
94
Rapid Response
60
Planetary Health
53
NCDs
49
NTDs
48
Caregiver
42
Global Health Education
38
Ebola
36
Conflict
36
Health Financing Toolbox
29
Refugee
16
Disability
16
Specific Hazards
14
Polio
11
Natural Hazards
9
Cholera
4
Social Ethics
4
Zika
3
Health Financing
2
South Sudan
1
The climate crisis has many consequences – among them widespread health impacts that will lead to immense societal, ecological, and economic harm.
Over the past two decades multiple large-scale reviews on climate change and health have made clear the need for a multi-sectoral approach to target t...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
After a decade of crisis, Syria remains one of the world’s most complex humanitarian crises. Continued hostilities, new and protracted displacement, increased returns and the sustained destruction of communities have impacted Syrians’ lives and futures in a devastating way. The 2021 Humanitarian...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The aim of the present paper is to review capacity building in public health nutrition (PHN), the need for which has been stressed for many years by a range of academics, national and international organisations. Although great strides have been made worldwide in the science of nutrition, there rema...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
Specifically the Strategy focuses on five strategic objectives:
commitment to action on Healthy Ageing in every country;
developing age-friendly environments;
aligning health systems to the needs of older populations;
developing sustainable and equitable systems for providing lon...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
The following checklist can help hospitals assess and improve their preparedness for responding to a community-wide outbreak of COVID-19. Each hospital will need to adapt this checklist to meet its unique needs and circumstances. This checklist should be used as one of several tools for evaluating c...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
The National Asthma Education Programme (NAEP) is a registered non-profit organisation whose mission is to provide asthma education to healthcare professionals, patients and the lay public. It was founded in 1994 by Dr Mike Greenblatt and Profs Dave Luyt and Robin Green. This year NAEP celebrates it...
Phil. Trans. R. Soc. B (2010) 365, 2959–2971; doi:10.1098/rstb.2010.0143.
Agricultural ecosystems provide humans with food, forage, bioenergy and pharmaceuticals and are essential to human wellbeing. These systems rely on ecosystem services provided by natural ecosystems, including pollination, b...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
